Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients P Basnyat, M Pesu, M Söderqvist, A Grönholm, S Liimatainen, M Peltola, ... BMC neurology 20, 1-8, 2020 | 23 | 2020 |
Semiautomated classification of nocturnal seizures using video recordings J Peltola, P Basnyat, S Armand Larsen, T Østerkjærhuus, ... Epilepsia 64, S65-S71, 2023 | 19 | 2023 |
Analysis of apoptosis-related genes in patients with clinically isolated syndrome and their association with conversion to multiple sclerosis S Hagman, M Kolasa, P Basnyat, M Helminen, M Kähönen, P Dastidar, ... Journal of Neuroimmunology 280, 43-48, 2015 | 19 | 2015 |
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients P Basnyat, S Hagman, M Kolasa, K Koivisto, A Verkkoniemi-Ahola, ... Multiple sclerosis and related disorders 4 (4), 334-338, 2015 | 15 | 2015 |
JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients P Basnyat, E Virtanen, I Elovaara, S Hagman, E Auvinen Journal of NeuroVirology 23, 734-741, 2017 | 13 | 2017 |
Clinical utility of a video/audio-based epilepsy monitoring system Nelli P Basnyat, J Mäkinen, JT Saarinen, J Peltola Epilepsy & Behavior 133, 108804, 2022 | 11 | 2022 |
EpiTrack is a feasible tool for assessing attention and executive functions in patients with refractory epilepsy N Lähde, P Basnyat, H Lehtinen, S Rainesalo, E Rosti-Otajärvi, J Peltola Epilepsy & Behavior 115, 107691, 2021 | 10 | 2021 |
Elevated IL-6 plasma levels are associated with GAD antibodies-associated autoimmune epilepsy P Basnyat, M Peltola, J Raitanen, S Liimatainen, S Rainesalo, M Pesu, ... Frontiers in Cellular Neuroscience 17, 1129907, 2023 | 8 | 2023 |
Evaluation of toxicity of pharmaceuticals to the activated sludge treatment plant P Basnyat | 7 | 2011 |
A 1-year follow-up study on immunological changes following deep brain stimulation in patients with epilepsy P Basnyat, S Järvenpää, J Raitanen, M Pesu, K Lehtimäki, J Peltola Scientific Reports 11 (1), 13765, 2021 | 5 | 2021 |
Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis P Basnyat, ML Sumelahti, T Lehtimäki, I Elovaara, S Hagman Journal of Neuroimmunology 335, 577020, 2019 | 4 | 2019 |
The Regulation of Plasma Interleukin‐6 Levels Is Modified by Hippocampal Sclerosis and Its Lateralization in Drug‐Resistant Temporal Lobe Epilepsy M Peltola, P Basnyat, S Liimatainen, S Rainesalo, M Pesu, J Peltola Acta Neurologica Scandinavica 2023 (1), 3030625, 2023 | 2 | 2023 |
Treatment outcomes in women with idiopathic generalized epilepsy R Kiiski, P Basnyat, J Raitanen, S Rainesalo, J Peltola, J Mäkinen Acta Neurologica Scandinavica 145 (4), 423-433, 2022 | 2 | 2022 |
The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis L Juutinen, K Ahinko, S Hagman, P Basnyat, O Jääskeläinen, SK Herukka, ... Multiple Sclerosis and Related Disorders 85, 105517, 2024 | 1 | 2024 |
Longitudinal EpiTrack assessment of executive functions following vagus nerve stimulation therapy in patients with drug‐resistant epilepsy N Lähde, P Basnyat, J Raitanen, K Lehtimäki, E Rosti‐Otajärvi, J Peltola Epilepsia Open 9 (1), 150-163, 2024 | 1 | 2024 |
Complex executive functions assessed by the trail making test (TMT) part B improve more than those assessed by the TMT part A or digit span backward task during vagus nerve … N Lähde, P Basnyat, J Raitanen, L Kämppi, K Lehtimäki, E Rosti-Otajärvi, ... Frontiers in psychiatry 15, 1349201, 2024 | | 2024 |
Hippocampal sclerosis is associated with celiac disease type immunity in patients with drug-resistant temporal lobe epilepsy M Peltola, K Kaukinen, P Basnyat, J Raitanen, K Haimila, S Liimatainen, ... Journal of Neurology, 1-9, 2024 | | 2024 |
Longitudinal assessment of executive functions following vagus nerve stimulation therapy by using EpiTrack in patients with drug-resistant epilepsy N Lahde, P Basnyat, J Raitanen, K Lehtimaki, S Rainesalo, ... EPILEPSIA 64, 423-423, 2023 | | 2023 |
Indications for the use of intravenous second-line antiseizure medications in an emergency room setting T Pöytäkangas, JT Saarinen, P Basnyat, S Rainesalo, J Peltola Epilepsy Research 196, 107218, 2023 | | 2023 |
Research Article The Regulation of Plasma Interleukin-6 Levels Is Modified by Hippocampal Sclerosis and Its Lateralization in Drug-Resistant Temporal Lobe Epilepsy M Peltola, P Basnyat, S Liimatainen, S Rainesalo, M Pesu, J Peltola | | 2023 |